Skip to content

Comparison of analgesic efficacy of Local Wound Infiltration with Levobupivacaine Plus Dexmedetomidine And Ropivacaine Plus Dexmedetomidine in Lower Abdominal Surgeries : A Randomised controlled trial

COMPARISON OF ANALGESIC EFFICACY OF LOCAL WOUND INFILTRATION WITH LEVOBUPIVACAINE PLUS DEXMEDETOMIDINE AND ROPIVACAINE PLUS DEXMEDETOMIDINE IN LOWER ABDOMINAL SURGERIES: A RANDOMISED CONTROLLED TRIAL - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065598
Enrollment
120
Registered
2024-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ropivacaine(0.25%) Plus Dexmedetomidine(100mcg): Control-Levobupivacaine (0.25%) Plus Dexmedetomidine study group Ropivacaine(0.25%) plus dexmedetomidine to compare the analgesic effic

Sponsors

Dr G Vignesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with ASA classification I & II Age of 18 to 60yrs Posted for elective lower abdominal surgeries Surgical duration of 1hr to 2hrs

Exclusion criteria

Exclusion criteria: Patient Refusal Allergic to local anaesthetics Failed Sub Arachnoid Block getting converted to GA Patchy Sub Arachnoid Block Obese Individual Lower Segment Caesarean Section

Design outcomes

Primary

MeasureTime frame
To Compare the efficacy of post operative analgesia of two drugs at 30mins,4hrs,8hrs,12hrs,20hrs, 24hrs and their analgesic duration Timepoint: To Compare the efficacy of post operative analgesia of two drugs at 30mins,4hrs,8hrs,12hrs,20hrs, 24hrs and their analgesic duration

Secondary

MeasureTime frame
Frequency of rescue analgesia whenever VAS score more than or equal to 4 in first 24hrsTimepoint: 4hrs,8hrs,12hrs,20hrs, 24hrs

Countries

India

Contacts

Public ContactDr G Vignesh

Karpaga Vinayaga Institute Of Medical Sciences and Research Centre

mmm.slazenger@gmail.com9791990979

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026